Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes
Purpose. To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) in patients with acute retinal artery occlusion (RAO). Secondarily, to analyse the epidemiology and the clinical approach. Methods. Retrospective study of 13 patients submitted to HBOT between 2013 and 2018. The analyse...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/9765938 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832547593878503424 |
---|---|
author | Ana Sofia Lopes Rita Basto Susana Henriques Luísa Colaço Filomena Costa e Silva Isabel Prieto Francisco Guerreiro |
author_facet | Ana Sofia Lopes Rita Basto Susana Henriques Luísa Colaço Filomena Costa e Silva Isabel Prieto Francisco Guerreiro |
author_sort | Ana Sofia Lopes |
collection | DOAJ |
description | Purpose. To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) in patients with acute retinal artery occlusion (RAO). Secondarily, to analyse the epidemiology and the clinical approach. Methods. Retrospective study of 13 patients submitted to HBOT between 2013 and 2018. The analysed parameters consisted of: systemic history, time between symptoms onset and treatment, initial approach, number of HBOT sessions, complications of HBOT and best corrected visual acuity—BCVA (of the total sample, central RAO—CRAO—group, and branch RAO—BRAO group). Results. Arterial hypertension was the most prevalent systemic risk factor (53.8%). Initial therapies were 100% normobaric oxygen administration, topical and oral hypotensive medication, eye massage and aspirin. CRAO was observed in 69.2% and BRAO in 30.8% of the cases, with clinically significant visual improvement (a decrease in logMAR of 0.3) in 55.5% and 75%, respectively. Time between symptoms onset and treatment had a median of 9 hours. The median number of HBOT sessions was 7, without complications. Conclusions. HBOT provide BCVA improvement in patients with RAO, when it is performed in an early time after the symptom onset. It seems to be an effective and safe therapeutic option for a pathology that still remains without approved treatment. |
format | Article |
id | doaj-art-a795b40002e64e5db5a45aa07fd56dc1 |
institution | Kabale University |
issn | 2090-6722 2090-6730 |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Ophthalmological Medicine |
spelling | doaj-art-a795b40002e64e5db5a45aa07fd56dc12025-02-03T06:44:16ZengWileyCase Reports in Ophthalmological Medicine2090-67222090-67302019-01-01201910.1155/2019/97659389765938Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual OutcomesAna Sofia Lopes0Rita Basto1Susana Henriques2Luísa Colaço3Filomena Costa e Silva4Isabel Prieto5Francisco Guerreiro6Department of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalDepartment of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalDepartment of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalDepartment of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalDepartment of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalDepartment of Ophthalmology of Professor Doutor Fernando Fonseca E.P.E. Hospital (Amadora-Sintra), Lisbon, PortugalUnderwater and Hyperbaric Medicine Center, Armed Forces Hospital—Lisbon Pole, Lisbon, PortugalPurpose. To evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) in patients with acute retinal artery occlusion (RAO). Secondarily, to analyse the epidemiology and the clinical approach. Methods. Retrospective study of 13 patients submitted to HBOT between 2013 and 2018. The analysed parameters consisted of: systemic history, time between symptoms onset and treatment, initial approach, number of HBOT sessions, complications of HBOT and best corrected visual acuity—BCVA (of the total sample, central RAO—CRAO—group, and branch RAO—BRAO group). Results. Arterial hypertension was the most prevalent systemic risk factor (53.8%). Initial therapies were 100% normobaric oxygen administration, topical and oral hypotensive medication, eye massage and aspirin. CRAO was observed in 69.2% and BRAO in 30.8% of the cases, with clinically significant visual improvement (a decrease in logMAR of 0.3) in 55.5% and 75%, respectively. Time between symptoms onset and treatment had a median of 9 hours. The median number of HBOT sessions was 7, without complications. Conclusions. HBOT provide BCVA improvement in patients with RAO, when it is performed in an early time after the symptom onset. It seems to be an effective and safe therapeutic option for a pathology that still remains without approved treatment.http://dx.doi.org/10.1155/2019/9765938 |
spellingShingle | Ana Sofia Lopes Rita Basto Susana Henriques Luísa Colaço Filomena Costa e Silva Isabel Prieto Francisco Guerreiro Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes Case Reports in Ophthalmological Medicine |
title | Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes |
title_full | Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes |
title_fullStr | Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes |
title_full_unstemmed | Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes |
title_short | Hyperbaric Oxygen Therapy in Retinal Arterial Occlusion: Epidemiology, Clinical Approach, and Visual Outcomes |
title_sort | hyperbaric oxygen therapy in retinal arterial occlusion epidemiology clinical approach and visual outcomes |
url | http://dx.doi.org/10.1155/2019/9765938 |
work_keys_str_mv | AT anasofialopes hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT ritabasto hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT susanahenriques hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT luisacolaco hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT filomenacostaesilva hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT isabelprieto hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes AT franciscoguerreiro hyperbaricoxygentherapyinretinalarterialocclusionepidemiologyclinicalapproachandvisualoutcomes |